Treatment Decisions Based on EF ≥50% Require More Robust Statistical Validation. Synthesis, [S. l.], v. 2, n. 4, 2026. Disponível em: https://synthesis-medicine.org/index.php/journal/article/view/9. Acesso em: 30 jul. 2026.